Nuwellis (NUWE) Profit After Tax (QoQ) (2011 - 2026)
Nuwellis (NUWE) Profit After Tax (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn |
| 10 | Nuwellis | 115,607.70 | -1.97 Mn | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.49% |
| Dec 31, 2025 | -618.63% |
| Sep 30, 2025 | 103.72% |
| Jun 30, 2025 | -316.21% |
| Mar 31, 2025 | -105.45% |
| Dec 31, 2024 | -162.26% |
| Sep 30, 2024 | 130.52% |
| Jun 30, 2024 | -78.41% |
| Mar 31, 2024 | 21.40% |
| Dec 31, 2023 | -63.47% |
| Sep 30, 2023 | 30.44% |
| Jun 30, 2023 | 25.29% |
| Mar 31, 2023 | -255.73% |
| Dec 31, 2022 | 52.89% |
| Sep 30, 2022 | 9.71% |
| Jun 30, 2022 | 4.18% |
| Mar 31, 2022 | -3.30% |
| Dec 31, 2021 | 17.87% |
| Sep 30, 2021 | -11.44% |
| Jun 30, 2021 | 9.39% |